Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
暂无分享，去创建一个
P. Sonneveld | E. Vellenga | B. van der Holt | M. V. van Oers | J. Cornelissen | H. Lokhorst | P. Wijermans | A. Croockewit | M. Schaafsma | P. Westveer | C. Segeren | Gregor E G Verhoe